When Iris Apfel passed away last year, she left behind a vivid legacy, one colored by her interior design practice and her ...
Initial clinical observations suggest high level of T cells reprogramming and CAR-T expansion at the starting dose without lymphodepletion At 28 ...
SEATTLE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback